Andelyn Biosciences, Inc., a cell and gene therapy CDMO, has expanded its AAV Curator Platform offering and License Agreement with the Broad Institute of MIT and Harvard to include the Stanton Lab CNS (Central Nervous System) capsids. Developed by researchers at the Broad Institute, these plasmids produce adeno-associated viruses (AAVs) that increase brain transduction and reduce tropism for the liver and other peripheral organs. The expanded agreement is an extension of Andelyn’s MyoAAV plas...